Table 1. Demographics.
| Demographics | Value |
|---|---|
| Age (median) (years) | 66 |
| Male:female (%) | 83:17 |
| Stage at time of testing (n) | |
| I | 6 |
| II | 6 |
| III | 8 |
| IV | 15 |
| Site of extrahepatic metastases (n) | |
| Adrenal | 4 |
| Brain | 1 |
| Skull | 1 |
| Lung | 4 |
| Spleen | 1 |
| Nodal metastasis (n) | |
| Yes | 6 |
| No | 29 |
| Vascular invasion (n) | |
| Yes | 7 |
| No | 28 |
| Biopsy (n) | |
| Yes | 13 |
| No | 22 |
| Child-Pugh | |
| A | 27 |
| B | 7 |
| C | 1 |
| Median # of prior lines of systemic therapy | 0 |
| Range of # of prior lines of systemic therapy | 0–3 |
| Prior locoregional therapy (LRT) (yes:no) (%) | 57:43 |
| Timing of LRT (before:after) (%) | 95:5 |
| If before, median # of days | 240 |
| Timing of ctDNA collection (n) | |
| Prior to any | 12 |
| Middle of treatment | 3 |
| At the time of progression | 20 |
ctDNA, circulation tumor DNA.